Ionis Pharmaceuticals
IONS
IONS
322 hedge funds and large institutions have $6.11B invested in Ionis Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 84 increasing their positions, 114 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.96% less ownership
Funds ownership: 94.26% → 86.3% (-8%)
21% less call options, than puts
Call options by funds: $77.5M | Put options by funds: $98M
26% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 114
Holders
322
Holding in Top 10
6
Calls
$77.5M
Puts
$98M
Top Buyers
| 1 | +$84.4M | |
| 2 | +$54.6M | |
| 3 | +$21.1M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$20.6M |
| 5 |
Two Sigma Investments
New York
|
+$20.1M |
Top Sellers
| 1 | -$44.6M | |
| 2 | -$36M | |
| 3 | -$30.1M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$16.6M |
| 5 |
Los Angeles Capital Management
Los Angeles,
California
|
-$15.4M |